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Abstract The response of insulin-like growth factor-1 (IGF-1)
signalling and the capacity of skeletal muscle to adapt to
mechanical overload was studied using synergistic muscle
ablation. Overload of the plantaris and soleus resulted in marked
hypertrophy and activation of satellite cells (as indicated by
MyoD expression), particularly in young rats. Two muscle IGF-
1 splice variants were measured and found to be differentially
regulated at the RNA level. The significant changes associated
with the inability of the older muscles to respond to mechanical
overload included the considerably lower expression of the local
splice variant mechano growth factor, and the failure to up-
regulate IGF-1 receptor and MyoD mRNA. ß 2001 Federa-
tion of European Biochemical Societies. Published by Elsevier
Science B.V. All rights reserved.
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1. Introduction
Loss of muscle mass (sarcopenia) is one of the major causes
of disability in elderly people. The inability to generate
enough power to adjust posture results in the elderly falling
and breaking bones that are brittle due to osteoporosis [1].
The decline in function and plasticity of skeletal muscle is also
characterised by impaired mechanisms of regeneration and
repair [2,3]. One of the best de¢nitions of ageing is the even-
tual breakdown of tissue maintenance [4], and because of the
post-mitotic nature of skeletal muscle tissue, its ability to re-
generate and e¡ect repair depends on a population of quies-
cent mononucleated stem cells known as satellite cells [5].
Therefore, it is likely that the decline in the number of satellite
cells and/or in their proliferative capacity in senescence con-
tributes to the pathology of muscle ageing [7^9].
The post-natal growth spurt that occurs early in life is
largely regulated by growth hormone (GH) produced in the
pituitary, which in turn induces the production of insulin-like
growth factor-1 (IGF-1) by the liver. In later life, the systemic
IGF-1 is still important for general tissue maintenance and
well being of the body as a whole. One noticeable change
during ageing is the decline in the circulating GH and IGF-
1 levels. However, GH therapy in elderly adults has had only
moderate e¡ects on the function of muscle [10]. On the other
hand, virally mediated local expression of IGF-1 and the over-
expression of muscle IGF-1 in transgenic rodents has been
shown to induce hypertrophy [11] and reverse the age-related
muscle atrophy [8,12].
Although IGF-1 yields a simple mature peptide, its gene
structure and patterns of expression are complex. In addition
to its gene transcription being regulated by two promoters,
IGF-1 splice variants di¡er in their precursor mRNA sequen-
ces, resulting in mature transcripts encoding at least four IGF-
1 precursor proteins [13]. Two forms produced locally in ac-
tive muscle appear to be positive regulators of muscle hyper-
trophy [14]. One of these, IGF-1Ea, has a similar structure to
the major endocrine form produced by the liver. It has been
given various abbreviations including muscle liver-type IGF-1
[14] and muscle IGF-1 [15]. The other isoform, which is the
IGF-1Eb in rodents and corresponds to IGF-1Ec in humans,
is only markedly up-regulated in exercised and in damaged
muscle and has been named mechano growth factor (MGF)
[16,17].
Measurements of expression levels of IGF-1 at di¡erent
ages, in resting muscle, have failed to show any di¡erences
in both mRNA and peptide levels [18]. However, this work
has not involved exercise studies or distinguished between
di¡erent IGF-1 isoforms. Muscle has an intrinsic ability to
adapt to an increased load by undergoing hypertrophy. The
role of IGF-1 in muscle hypertrophy is supported by the ob-
servation that over-expression of IGF-1 both in vitro and in
vivo induces hypertrophy [15,19,20]. IGF-1 has also been
shown to be involved in the synthesis of muscle-speci¢c pro-
teins, required for satellite cell proliferation and di¡erentiation
into mature myotubes [21]. It was therefore considered impor-
tant to determine the expression of MGF, IGF-1Ea, and IGF-
1 receptors in relation to the ability to adapt to mechanical
overload at di¡erent ages. Activated satellite cells express
MyoD, a member of muscle regulatory transcription factors
[22]. Therefore, by measuring the expression of this myogenic
factor, some light may be shed on the functional implications
of the age-related ability of muscle to express MGF and IGF-
1Ea.
As muscle mass is known to increase in response to over-
load and stretch, it was decided to use the method of syner-
gistic muscle tenotomy, which stretches as well as increases
the load on the intact muscle. The resulting hypertrophy, as
shown by Goldberg [23] in hypophysectomised rats, is inde-
pendent of the GH/IGF-1 axis. Therefore, this system ap-
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peared to be appropriate for studying the early response of
autocrine IGF-1 splice variants to overload. Caloric restric-
tion is the only intervention known to retard ageing in mam-
mals. Studies in Caenorhabditis elegans suggest that the IGF-
1/insulin system may integrate systems that de¢ne an organ-
isms rate of ageing. Dietary intervention has been shown to
delay the atrophic changes related to senescent muscle [24].
The e¡ect of caloric restriction on the expression of local
IGF-1s was therefore also investigated.
2. Materials and methods
2.1. Animal experiments
Male Sprague^Dawley rats were weaned at 21 days and at 3 months,
randomly allocated into ad libitum-fed (AD) and diet-restricted (DR)
groups, which were individually caged. AD animals had unlimited
access to food, while DR rats were fed an identical diet to 70% of
the AD food-group intake. All rats were kept in conditions of con-
stant temperature and light-controlled environment (12:12 h light^
dark cycles). Three di¡erent sub-groups of 18 rats each were classi¢ed
in each of the AD and DR groups as 3 month (young), 12 month
(mature) and 24 month (old). All procedures were performed while
the animals were anaesthetised. Experiments were initiated by unilat-
eral excision of the distal gastrocnemius tendon as described by DeVol
[25], and sham operations were carried out on the contralateral leg,
which would then act as the control. After the animals recovered from
anaesthesia, they were observed to use both legs almost within 1 h.
They all survived until time of death at 1, 2, 3 and 5 days, when the
animals were again anaesthetised and then sacri¢ced. The plantaris
and soleus were immediately removed, weighed, and one part snap-
frozen in liquid nitrogen and stored at 370 ‡C.
2.2. RNA isolation and analysis
Total RNA was isolated by the guanidine thiocynate method of
Chomczynski and Saachi [26]. The extracted RNA was dissolved in
diethylpyrocarbonate-treated water and quanti¢ed spectrophotometri-
cally with the Gene spec I (Naka Instruments). The integrity of the
RNA was con¢rmed by visual inspection of ethidium bromide stained
18S and 28S ribosomal RNA under ultra violet light.
2.3. Reverse transcription
1 Wg of each sample of RNA was reverse-transcribed using Super-
script II reverse transcriptase (RT) (Gibco BRL) in a 20 Wl volume.
To facilitate the e⁄ciency of RT of transcripts expressed at low levels
such as MGF and IGF-1 receptor, short speci¢c primers annealing
50^100 base pairs downstream of the polymerase chain reaction
(PCR) reverse primers were used. Hence, a mixture of random hex-
amers and speci¢c decamers were used in the same reaction. The RT
primers for MGF and IGF-1 receptors are 5P-TTGCAGGTTGCT-3P
and 5P-GTACTACTACT-3P
2.4. Real-time quantitative PCR
Primers used for PCR are listed in Table 1. All the PCR primers
were designed using Omega Version 2.0 (Oxford Molecular) and syn-
thesised by Sigma Genosys. Real-time PCR was performed in the
Roche Lightcycler using SYBR green detection.
3. Results
3.1. E¡ect of loading
Five days after tendon ablation, there was an increase in the
wet weight of the synergistically overloaded plantaris muscle
of 60%, 35% and 20% in the young, mature and old rats,
respectively (Table 2).
3.2. E¡ect of loading and age on IGF-1, MGF, IGF-1R, and
MyoD gene expression.
A signi¢cant increase in IGF-1 receptor mRNA levels
(P6 0.05) was found in overloaded muscles of the young
rats when compared to the control levels, but not in mature
and old muscle (Fig. 1A). There was no signi¢cant change in
IGF-1Ea mRNA levels during ageing or after tenotomy in the
young, mature and old muscles. (Fig. 1B)
However, there was a signi¢cant increase in MGF mRNA
at all ages in overloaded muscle relative to control muscle
(Fig. 2A). This was very signi¢cant in young muscle
(P6 0.001), but less so for both mature and old muscles
(P6 0.05). The degree of increase in the old overloaded
muscle was markedly less than that in the young muscles.
(Fig. 2B)
With regard to MyoD expression, its baseline mRNA levels
Table 1
Primers used in the PCR in 5P to 3P direction
Gene Forward primer Reverse primer
IGF-1Ea GCTTGCTCACTTTACCAGC AATGTACTTCCTTCTGGGTCT
MGF GCTTGCTCACTTTACCAGC AAATGTACTTCCTTTCCTT
IGF-1 receptor GCATTGACATCCGCAACG ACTGTGAGGTTCGGAAGAGG
MyoD GGAGACAATCCTCAAGCGATGC AGCACCTGGTAAATCGGATTGG
Fig. 1. IGF-1 receptor mRNA (A) and IGF-1Ea mRNA (B) quanti-
¢cation 5 days after tenotomy. Values are þ S.E.M; n = 4/group.
*P6 0.05 signi¢cantly di¡erent from control. Experimental (E) is in
reference to the overloaded muscle, while control (C) refers to the
contralateral leg.
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were signi¢cantly higher in old muscle in comparison to those
of young muscle (P6 0.05; Fig. 3A). However, there was a
signi¢cant increase in the expression of MyoD in both young
(P6 0.001) and old overloaded muscles (P6 0.05). The degree
of increase in the old muscle was attenuated and far less than
that in the young muscle (P6 0.05; Fig. 3B).
3.3. E¡ect of caloric restriction
Caloric restriction had no signi¢cant e¡ect on the mRNA
levels of IGF-1Ea, MGF or IGF-1 receptors, in both the
control and overloaded muscles. Therefore, these results are
not presented.
3.4. Statistical analysis
The Student’s t-test was used to test the di¡erence in the
means of the overloaded and control muscles at the various
age groups. One-way analysis of variance was used to deter-
mine signi¢cant di¡erences among the means, with the level of
signi¢cance set at P6 0.05. For all groups n = 6. Values are
expressed as mean þ standard error of the mean (S.E.M.).
4. Discussion
This study showed for the ¢rst time that in muscle, IGF-1
mRNA isoforms are di¡erentially regulated in response to
mechanical overload. Increases in muscle IGF-1 have been
observed during work-induced compensatory overload, in re-
generating ¢bres after acute and chronic exercise and during
Table 2
Contralateral leg as control (C) and overloaded leg as experimental
(E) n = 6
Samples YC YE MC ME OC OE
Weight (g) 0.128 0.188 0.325 0.414 0.351 0.411
Standard deviation 0.026 0.033 0.065 0.047 0.074 0.067
Key: Young (Y) 3 month old rats; mature (M) 13 month old; old
(O) 24 month old.
Fig. 2. Quanti¢cation of MGF mRNA levels. A: After 5 days in
young (Y), mature (M) and old (O) samples. There is a signi¢cant
increase in MGF levels in overloaded muscle (E) compared to con-
trols (C) at all ages. B: Changes in MGF levels 1, 2 and 3 days
after surgery in overloaded muscles of young and old rats. Day 0
represents the levels in the contralateral legs, which serve as the
controls. The level of MGF increase in young is signi¢cantly higher
than that in the old after 24 h. In comparison to the old muscles,
MGF levels in the young continue to increase signi¢cantly after
1 day (**P6 0.001 and *P6 0.05).
Fig. 3. Quanti¢cation of MyoD mRNA levels after tenotomy. A:
Changes in MyoD mRNA after 1, 2 and 3 days in overloaded
muscles of young and old rats. Day 0 corresponds to levels in con-
trol muscle. Baseline MyoD levels are signi¢cantly higher in the
control muscle of old rats compared to young rats. There is a sig-
ni¢cant increase in MyoD levels after 1 day, which declines to con-
trol levels by day 2 (**P6 0.001 and *P6 0.05). B: Increase of
MyoD in old muscle is signi¢cantly less in comparison to that in
the young (P6 0.05).
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passive stretch in mammalian muscle [16,25,27^29]. However,
in previous work, no distinction was made between the di¡er-
ent transcripts. Indeed, the previously reported early increase
in IGF-1 gene expression may have been a re£ection of the
increase in MGF rather than IGF-1Ea mRNA. Local IGF-1
expression is likely to be dissociated from hepatic/circulatory
IGF-1 due to the localised e¡ects of hypertrophy observed in
only the overloaded muscle [29]. This suggests the presence of
a transient and activity-sensitive local trophic factor. Accumu-
lating evidence suggests that this is MGF, the mRNA of
which increases markedly in response to stretch and stimula-
tion [16,17].
MGF and IGF-1Ea splice variants, apparently yield the
same mature peptide, which is derived from the highly con-
served exons 3 and 4 of the IGF-1 gene. A mechanism of
extracellular endoproteolysis of the IGF-1 prohormone, re-
sults in the same mature peptide, but di¡erent E peptides
[30], which may function as independent growth factors [31].
It has been suggested that IGF-1 precursors could be pluri-
potenial, in a form analogous to that of prohormone pro-
opiomelanocortin and proglucagon [31]. Of particular interest
is the observation that a synthetic peptide derived from the rat
Eb domain induces proliferation in epithelial cells [31]. The
role of the growth promoting properties of the E peptide in
MGF, acting as a separate growth factor, is supported by
observation that muscle cell lines stably transfected with
MGF show greater proliferative rates of mononucleated
myocytes than in the control or in those cells transfected
with IGF-1Ea (Yang et al., unpublished data). Furthermore,
an antibody raised against the synthetic IGF-Eb-related pre-
cursor peptide can detect a protein product of immunological
similarity in human and mammalian tissues extracts [31].
The early induction of MGF, following mechanical over-
load, indicates that this may play an important role in the
increase in protein synthesis, proliferation and di¡erentiation
of satellite cells in response to stretch and damage. IGF-1
expressed by muscle is believed to increase protein synthesis
and to activate satellite cells. These proliferate, di¡erentiate
and fuse with the pre-existing muscle ¢bres [19]. In Q-irradi-
ated mouse skeletal muscle, where the proliferative capacity of
satellite cells has been destroyed, vector-delivered IGF-1 is
only able to induce partial hypertrophy [32]. Muscle response
to overload occurs in two phases [7]. At early time points, the
increase in muscle DNA and RNA content has been related to
the proliferation and di¡erentiation of satellite cells [19]. In
agreement with previous observations, there was a marked
transient increase in MyoD mRNA levels in both the young
and old rats 24 h after tendon ablation. Concurrent with data
from Musaro et al [33], old muscle expresses higher baseline
levels of myogenic factors, and after exercise, does not achieve
the same levels of increase as young muscle [33^36]. Although
it is not known why resting levels of MyoD should be higher,
it has been proposed that this may be a result of increased
denervation and impaired reinnervation phenomena that is
associated with ageing in muscle [34].
It is proposed that age-related loss in muscle mass is due to
the failure to activate satellite cells, which are needed to repair
the cumulative damage incurred by cycles of regeneration/de-
generation [12]. Restoration of muscle strength using virally
mediated over-expression of IGF-1 supports the hypothesis
that a de¢cit in local trophic factor may be linked to age-
related muscle atrophy. Exogenous locally infused IGF-1 re-
stores the satellite cell proliferative potential of immobilised
old skeletal muscle [8]. The signi¢cant decrease in baseline
levels of MGF with increasing age may partially explain the
decrease in proliferative capacity of satellite cells with ageing
[3,6,36]. The attenuated increase of MGF mRNA levels in old
muscle after tenotomy correlates well with the decreased ex-
pression of myogenic factors in senescent muscle subjected to
exercise.
The reduced plasticity of senescent muscle is also re£ected
in the lack of increase in IGF-1 receptor mRNA levels after
5 days of overload in the old muscle, compared to the young
animals. Both IGF-1 and IGF-II mediate their cellular e¡ects
by binding to the IGF-1 receptor. This activates a tyrosine
kinase cascade that has been correlated with the di¡erent cel-
lular e¡ects of IGFs. In particular, IGF-1 has been shown to
induce hypertrophy through the calcineurin/calmodulin path-
way [20]. The observed increase in IGF-1 receptor transcrip-
tion would serve to increase the e¡ects of IGF-1 in muscle.
The mechanism by which stretch may activate IGF-1 receptor
transcription is as yet unknown.
Cellular ageing in muscle is likely to be due to multiple
factors. However, the down-regulation of the IGF-1 system
particularly, the decrease in MGF mRNA levels as well as
IGF-1 receptor levels in response to overload, is likely to
play an important role in the impaired regenerative potential
of old skeletal muscle.
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